Men's knowledge of the human papillomavirus vaccine.
The FDA recently approved the use of the HPV quadrivalent vaccine, Gardasil, for the prevention of genital warts in males ages 9 through 26. This literature review seeks to examine men's knowledge of and interest in HPV vaccination as this could potentially affect vaccine uptake.
Nandwani
Monica Christine R
MC
Johns Hopkins University School of Medicine, Division of Gastroenterology, Baltimore City, MD, USA.
D000293:Adolescent; D000328:Adult; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D033182:Intention; D008297:Male; D008571:Men / Q000193:education* / Q000523:psychology; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000600:supply & distribution; D010342:Patient Acceptance of Health Care / Q000523:psychology / Q000706:statistics & numerical data; D010353:Patient Education as Topic; D018579:Patient Selection; D012107:Research Design; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000523:psychology / Q000706:statistics & numerical data
D053918:Papillomavirus Vaccines